Showing results (651-660 of 1,495) with videos related to
Sort By:
Pageof 150
Journal of Periodontology|July 11, 2023
Impact of N-terminal pro-B-type natriuretic peptide and related inflammatory biomarkers on periodontal treatment outcomes in patients with periodontitis: An explorative human randomized-controlled clinical trialGaetano Isola, Gianluca Martino Tartaglia, Simona Santonocito, et al.Joint Bone Spine|November 11, 2015
Occlusal and MRI characterizations in systemic sclerosis patients: A prospective study from Southern Italian cohortGiovanni Matarese, Gaetano Isola, Angela Alibrandi, et al.Allergologia Et Immunopathologia|July 1, 1996
Rush sublingual immunotherapy in Parietaria allergic patientsF P D'Ambrosio, L Ricciardi, S Isola, et al.Environmental Health Perspectives|October 1, 1993
Metabolism of 2-aminofluorene by human polymorphonuclear leukocytes: more evidence for the association between inflammation and cancerV J Isola, T C Hartman, S J Trumble, et al.The American Journal of Pathology|December 1, 1995
Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapyP Koivisto, E Hyytinen, C Palmberg, et al.Plos One|March 1, 2019
Real-time adaptive planning method for radiotherapy treatment delivery for prostate cancer patients, based on a library of plans accounting for possible anatomy configuration changesMaria Antico, Peter Prinsen, Francesco Cellini, et al.The Prostate|April 15, 2003
Expression of ERalpha and ERbeta in prostate cancerMarika J Linja, Kimmo J Savinainen, Teuvo L J Tammela, et al.Breast Cancer Research and Treatment|July 20, 2007
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancerLooket Dihge, Pär-Ola Bendahl, Dorthe Grabau, et al.European Urology|January 1, 1997
Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockadeC Palmberg, P Koivisto, E Hyytinen, et al.The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|August 13, 2013
Related factors to atazanavir plasma levels in a cohort of HIV positive individuals with undetectable viral loadAna Júlia Luz, Júlia Poeta, Rafael Linden, et al.Pageof 150